SKOLNICK PHIL

PrivateCIK: 1358116
Location

HACKENSACK, NJ

SKOLNICK PHIL (Chief Scientific Officer) received a stock award from OPIANT PHARMACEUTICALS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award
InsiderSKOLNICK PHILCIK 1358116
Officer· Chief Scientific Officer
Since Oct 2018
-93.75K
Net shares
Net seller
$471.0K
Total sold
0
Open market trades
0B · 0S
8
Total transactions
2K acquired · 95.75K disposed
Non-Derivative Transactions4

Common Stock

Direct
D · Disposition

Shares

9.81K

Price / share

$20.00

Trade value

$196.24K

% of position

45.5%
3/2/2023
21.55K11.74K

Common Stock

Direct
D · Disposition

Shares

11.74K

Price / share

$20.00

Trade value

$234.72K

% of position

New position
3/2/2023
11.74K0.00

Common Stock

Direct
A · Award

Shares

+2K

Price / share

Trade value

% of position

New position
3/2/2023
0.002K

Common Stock

Direct
D · Disposition

Shares

2K

Price / share

$20.00

Trade value

$40K

% of position

New position
3/2/2023
2K0.00
Total

Net shares

21.55K

Net value

-$470.96K

Derivative Transactions4

Stock Option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

40K shares

Shares

40K

Strike price

9.0

Held after

0.00

Exercisable

3/2/2023

Stock Option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

13.20K shares

Shares

13.20K

Strike price

13.61

Held after

0.00

Exercisable

3/2/2023

Common Stock

Direct
D · Disposition
Converts to

Common Stock

8.25K shares

Shares

8.25K

Strike price

13.6

Held after

0.00

Exercisable

3/2/2023

Stock Option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

10.75K shares

Shares

10.75K

Strike price

12.15

Held after

0.00

Exercisable

3/2/2023
SKOLNICK PHIL — Insider Transaction (Form 4) Filed Mar 3, 2023 | Finecho